Many clinical studies begin with a reassuring sense of security: the protocol is approved, the documentation is complete, regulatory requirements are met.<\/p>
Yet anyone who actually works in clinical research knows this: initial compliance is not the same as safety.<\/p>
The real question is not whether a study is compliant today, it is what happens when something changes.<\/p>
Because something always does.<\/p>
A compliant study<\/strong> meets formal regulatory requirements and satisfies expectations at approval. It remains stable as long as everything follows the plan.<\/p> A governable study<\/strong>, instead, is designed to operate under real conditions. It is able to absorb pressure without losing control. It continues to protect patients, sponsors, and clinical decisions even when reality diverges from the protocol.<\/p> The difference does not lie in the regulations themselves, it lies in how the study was designed to function over time.<\/p> Most serious issues do not come from obvious mistakes. They originate from early, often invisible decisions:<\/p>The invisible decisions that define safety<\/h2>